Support Us : info@JSRSD-society.org
Treatment for Gaucher disease type 3 is critical for minimizing symptoms and lasting damage to the body.
Gaucher disease treatment includes enzyme replacement therapy (ERT) and substrate reduction therapy (SRT).
Enzyme replacement therapy (ERT) balances low levels of GCase enzyme in patients with Gaucher disease so their bodies can break down glucocerebroside. ERT requires intravenous (IV) enzyme infusions, typically every 2 weeks or so.
Substrate reduction therapy (SRT) is a newer treatment that works differently than ERT. SRT is oral medications that decrease the amount of glucocerebroside that the body makes, reducing excess buildup. Some patients find it more convenient than receiving ERT infusions.